Dr. Mojtaba Noofeli
Affiliation:
Razi Vaccine & Serum Research Institute (RVSRI), AREEO, Karaj, Iran — Head of Human Bacterial Vaccine Production & Research (DTP Department).
Pertussis Vaccines Outer Membrane Vesicles (OMV) Intranasal Booster (Razi Cov Pars)
Top 3 Highlights
- Led/co-led research on the Razi Cov Pars recombinant spike-protein COVID-19 vaccine, including a randomized, double-blind, placebo-controlled intranasal booster trial in adults demonstrating acceptable safety and immunogenicity.
- Co-authored Phase I and Preclinical studies on a combined intramuscular + intranasal regimen of Razi Cov Pars across animal models and healthy adults, supporting mucosal immunity strategies.
- Pioneered work on Outer Membrane Vesicles (OMVs) from Bordetella pertussis as a pertussis vaccine candidate — including extraction methods and immunogenicity evaluation from predominant local strains.
